[{"id":"c41ce400-a3f3-41d0-9d78-03836538a6de","acronym":"QUILT-2.025","url":"https://clinicaltrials.gov/study/NCT03552718","created_at":"2021-01-18T17:29:26.684Z","updated_at":"2024-07-02T16:35:44.727Z","phase":"Phase 1","brief_title":"QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.","source_id_and_acronym":"NCT03552718 - QUILT-2.025","lead_sponsor":"NantBioScience, Inc.","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 positive • HR positive • HR positive + HER-2 positive","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HR positive • HR positive + HER-2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e YE-NEO 001"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 16","initiation":"Initiation: 08/10/2018","start_date":" 08/10/2018","primary_txt":" Primary completion: 07/15/2025","primary_completion_date":" 07/15/2025","study_txt":" Completion: 12/30/2025","study_completion_date":" 12/30/2025","last_update_posted":"2023-06-26"}]